NASDAQ · RXST
RxSight, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for RXST: Nov 03, 2026
RxSight, Inc. Common Stock is expected to report earnings on 11/03/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 4 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.42. The reported EPS for the same quarter last year was $-0.24.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.42 | $-0.36 | $-0.49 | 4 |
| Dec 2026 | $0.07 | $0.25 | $-0.32 | 4 |
| Mar 2027 | $-0.36 | $-0.36 | $-0.36 | 1 |
| Jun 2027 | $-0.32 | $-0.32 | $-0.32 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
The Motley Fool · MarketBeat · Zacks · RTTNews- The Motley Fool · Aug 12, 7:01 PM EDTRxSight (RXST) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 6, 1:03 AM EDTRxSight Q2 Earnings Call HighlightsRxSight (NASDAQ:RXST) reported second-quarter revenue of $33.7 million, including $6.5 million recognized under its strategic collaboration with Alcon, while management withdrew its full-year 2026 financial guidance as new Chief Executive Officer Aziz Mottiwala conducts a broader
- Zacks · Aug 5, 6:10 PM EDTRxSight, Inc. (RXST) Reports Q2 Loss, Beats Revenue EstimatesRxSight (RXST) delivered earnings and revenue surprises of +47.62% and +2.56%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 3, 6:45 PM EDTUFP Technologies (UFPT) Beats Q2 Earnings and Revenue EstimatesUFP (UFPT) delivered earnings and revenue surprises of +16.34% and +8.85%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Jul 29, 10:00 AM EDTEarnings Preview: RxSight, Inc. (RXST) Q2 Earnings Expected to DeclineRxSight (RXST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks · Jul 28, 8:15 AM EDTIQVIA Holdings (IQV) Q2 Earnings and Revenues Beat EstimatesIQVIA (IQV) delivered earnings and revenue surprises of +4.31% and +1.63%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Jul 17, 3:50 AM EDTRxSight (RXST) Surges 6.1%: Is This an Indication of Further Gains?RxSight (RXST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- RTTNews · Jul 16, 2:24 AM EDTRxSight Names Aziz Mottiwala As CEO And Ron Kurtz As CMO Amid Standalone 2026 Sales Outlook Cut(RTTNews) – RxSight, Inc. (RXST), an ophthalmic medical device company, announced a planned leadership transition and named Aziz Mottiwala President and Chief Executive Officer (CEO), effective July 20, 2026, succeeding Ron Kurtz, who will continue to serve as Chief Medical Offic
- Zacks · Jul 13, 9:40 AM EDTAlcon & RxSight Collaborate to Develop Adjustable PCIOL TechnologyALC is developing adjustable presbyopia-correcting lenses that pair advanced optics with post-surgery light adjustment.
- MarketBeat · Jul 10, 10:01 PM EDTRxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 OutlookRxSight (NASDAQ:RXST) reported preliminary second-quarter financial results and provided updates on its product pipeline following a newly announced strategic collaboration agreement with Alcon, with management pointing to both near-term commercial headwinds and longer-term oppor
- RTTNews · Jul 7, 5:34 AM EDTRxSight Updates FY2026 Revenue Outlook After Alcon Deal; Cuts Product Sales Forecast; Stock Down(RTTNews) – RxSight, Inc. (RXST), a commercial-stage ophthalmic medical device company, announced preliminary financial results for the second quarter of 2026 and updated the full-year 2026 guidance following a strategic collaboration with Alcon Inc. (ALC), an eye care company sp
- RTTNews · Jul 7, 3:53 AM EDTAlcon Inks Partnership With RxSight To Develop Adjustable PICOLs For Deal Value Up To $200 Mln(RTTNews) – Alcon Inc. (ALC), an eye care company specializing in surgical and vision care products, on Monday announced that it has entered into a non-exclusive collaboration with RxSight, Inc. (RXST), an ophthalmic medical device company, to develop adjustable presbyopia-correc
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for RxSight, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.